Literature DB >> 27966035

Network meta-analysis as a tool for improving the effectiveness assessment of biosimilars based on both direct and indirect evidence: application to infliximab in rheumatoid arthritis.

Andrea Messori1, Sabrina Trippoli2, Claudio Marinai2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27966035     DOI： 10.1007/s00228-016-2177-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

1.  Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials.

Authors:  Ludovic Trinquart; Nassima Attiche; Aïida Bafeta; Raphaël Porcher; Philippe Ravaud
Journal:  Ann Intern Med       Date:  2016-04-19       Impact factor: 25.391

Review 2.  Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis.

Authors:  Glen S Hazlewood; Cheryl Barnabe; George Tomlinson; Deborah Marshall; Dan Devoe; Claire Bombardier
Journal:  BMJ       Date:  2016-04-21
  2 in total
  2 in total

1.  Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.

Authors:  Marco Chiumente; Andrea Messori
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-08-23       Impact factor: 5.346

2.  Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients.

Authors:  Isabel Puértolas; Alberto Frutos Pérez-Surio; María Aránzazu Alcácera; Raquel Andrés; María Del Tránsito Salvador
Journal:  Eur J Clin Pharmacol       Date:  2017-11-19       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.